Cleared Traditional

K061247 - DIASORIN LIAISON TREPONEMA ASSAY (FDA 510(k) Clearance)

Jul 2006
Decision
89d
Days
Class 2
Risk

K061247 is an FDA 510(k) clearance for the DIASORIN LIAISON TREPONEMA ASSAY. This device is classified as a Enzyme Linked Immunoabsorption Assay, Treponema Pallidum (Class II - Special Controls, product code LIP).

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on July 31, 2006, 89 days after receiving the submission on May 3, 2006.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3830.

Submission Details

510(k) Number K061247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 2006
Decision Date July 31, 2006
Days to Decision 89 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LIP — Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3830